GAZI UNIVERSITY INFORMATION PACKAGE - 2019 ACADEMIC YEAR
Course Structure Diagram with Credits - YÜKSEK LİSANS
1.Semester Course Plan | ||||
Code | Course Title | Compulsory/Elective | ||
RESTRICTED ELECTIVE COURSE | Elective | 0+0+3(Hours) | 7,5 | |
RESTRICTED ELECTIVE COURSE | Elective | 0+0+3(Hours) | 7,5 | |
RESTRICTED ELECTIVE COURSE | Elective | 0+0+3(Hours) | 7,5 | |
RESTRICTED ELECTIVE COURSE | Elective | 0+0+3(Hours) | 7,5 | |
Total ECTS credits: | 30 | |||
2.Semester Course Plan | ||||
Code | Course Title | Compulsory/Elective | ||
RESTRICTED ELECTIVE COURSE | Elective | 0+0+3(Hours) | 7,5 | |
RESTRICTED ELECTIVE COURSE | Elective | 0+0+3(Hours) | 7,5 | |
RESTRICTED ELECTIVE COURSE | Elective | 0+0+3(Hours) | 7,5 | |
SEMINAR | Compulsory | 0+0+3(Hours) | 7,5 | |
Total ECTS credits: | 30 | |||
3.Semester Course Plan | ||||
Code | Course Title | Compulsory/Elective | ||
MS THESIS | Compulsory | 0+0+15(Hours) | 15 | |
SPECIAL STUDIES IN MS | Compulsory | 0+0+15(Hours) | 15 | |
Total ECTS credits: | 30 | |||
4.Semester Course Plan | ||||
Code | Course Title | Compulsory/Elective | ||
MS THESIS | Compulsory | 0+0+15(Hours) | 15 | |
SPECIAL STUDIES IN MS | Compulsory | 0+0+15(Hours) | 15 | |
Total ECTS credits: | 30 | |||
COURSES | ||||
Code | Course Title | Compulsory/Elective | ECTS | |
1110999 | MASTER SCIENCE THESIS PERIOD | Compulsory | 30 | |
2110999 | SPECIAL STUDIES IN MSC. | Compulsory | 3 | |
6110999 | THESIS PREPARATION | Compulsory | 1 | |
FTE-1002 | SEMINAR | Compulsory | 2 | |
FTE-1110 | SCIENTIFIC RESEARCH METHODS AND RESEARCH-PUBLICATION ETHICS | Compulsory | 6 | |
FTE-1120 | PRE-FORMULATION | Compulsory | 8 | |
FTE-1130 | KINETIC PRINCIPLES AND STABILITY | Compulsory | 8 | |
FTE-1140 | BASIC PHARMACOKINETICS AND BIOPHARMACEUTICS | Compulsory | 8 | |
FTE-2002 | SEMINAR | Compulsory | 2 | |
FTE-2200 | DISSOLUTION RATE AND RELEASE KINETICS FROM DOSAGE FORMS | Compulsory | 8 | |
FTE-1010 | BASIC PROCESS IN THE PHARMACEUTICAL TECHNOLOGY | Elective | 7 | |
FTE-1011 | BASIC PROCESS IN THE PHARMACEUTICAL TECHNOLOGY-PRACTICE | Elective | 7 | |
FTE-1020 | PHYSICAL PHARMACY | Elective | 8 | |
FTE-1031 | PRE-FORMULATION – PRACTICE | Elective | 7 | |
FTE-1041 | KINETIC PRINCIPLES AND STABILTY-PRACTICE | Elective | 7 | |
FTE-1050 | PARENTERAL SOLUTION AND OTHER STERIL PRODUCT TECHNOLOGY | Elective | 7 | |
FTE-1051 | PARENTERAL SOLUTION AND OTHER STERIL PRODUCT TECHNOLOGY- PRACTICE | Elective | 7 | |
FTE-1070 | RADIOPHARMACEUTICS I | Elective | 8 | |
FTE-1081 | BASIC PHARMACOKINETICS AND BIOPHARMACEUTICS-PRACTICE | Elective | 7 | |
FTE-1090 | PHARMACEUTICAL BIOTECHNOLOGY I:BASIC PRINCIPLES | Elective | 8 | |
FTE-2020 | TABLET TECHNOLOGY | Elective | 8 | |
FTE-2021 | TABLET TECHNOLOGY - PRACTICE | Elective | 8 | |
FTE-2030 | MULTIPLE PHASE SYSTEMS | Elective | 7 | |
FTE-2031 | MULTIPLE PHASE SYSTEMS I –PRACTICE | Elective | 7 | |
FTE-2040 | CONTROLLED RELEASE DRUG DELIVERY TECHNOLOGY I. | Elective | 8 | |
FTE-2041 | CONTROLLED RELEASE DRUG DELIVERY TECHNOLOGY -PRACTICE | Elective | 7 | |
FTE-2050 | TECHNOLOGY OF SEMI SOLID DOSAGE FORMS I | Elective | 7 | |
FTE-2051 | TECHNOLOGY OF SEMI SOLID DOSAGE FORMS I. -PRACTICE | Elective | 7 | |
FTE-2090 | CELL CULTURE IN DRUG DEVELOPMENT AND EVALUATION | Elective | 7 | |
FTE-2140 | PHARMACEUTICAL BIOTECHNOLOGY II. MONOCLONAL DRUG MANUFACTURING TECHNOLOGY | Elective | 7 | |
FTE-2171 | DISSOLUTION RATE AND THE RELEASE KINETIC FROM DOSAGE FORMS-PRACTICE | Elective | 7 | |
FTE-2180 | THE EXCIPIENTS USED IN PHARMACEUTICAL TECHNOLOGY | Elective | 8 | |
FTE-2190 | GOOD MANUFACTURING PRACTICES AND VALIDATION | Elective | 8 | |
SBE-ERA-85 | ERASMUS INTERNSHIP | Elective | 3 |